• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRG
Click for more information
5.00% 21.0¢

FORGE RESOURCES LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
FRG
Ann: Applications, Redemptions, Units on Issue and OTC 30.9.2024 		09:21 0 80
09:21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  80 
FRG
Ann: Quarterly Portfolio Holdings as at 31 July 2024 		30/09/24 0 87
30/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  87 
FRG
Ann: Annual Report 30 June 2024 		25/09/24 0 85
25/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  85 
FRG
Ann: Applications, Redemptions, Units on Issue and OTC 31.8.2024 		06/09/24 0 118
06/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  118 
FRG
Ann: Applications, Redemptions, Units on Issue and OTC 31.7.2024 		15:53 0 122
15:53 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  122 
FRG
Ann: Quarterly Correlation Report - June 2024 		15/07/24 0 82
15/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  82 
FRG
Ann: Applications, Redemptions, Units on Issue and OTC 30.6.2024 		04/07/24 0 123
04/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  123 
FRG
Ann: DRP price announcement for the month ended 30 June 2024 		02/07/24 0 124
02/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 

See All Discussions arrow Created with Sketch.

Timeline

Applications, Redemptions, Units on Issue and OTC 30.9.2024
07 Oct 09:01
 
Quarterly Portfolio Holdings as at 31 July 2024
30 Sep 11:03
 
Annual Report 30 June 2024
25 Sep 15:09
 
Applications, Redemptions, Units on Issue and OTC 31.8.2024
06 Sep 09:01
 
Applications, Redemptions, Units on Issue and OTC 31.7.2024
07 Aug 15:33
 
Quarterly Correlation Report - June 2024
15 Jul 16:16
 
View More arrow Created with Sketch.

Featured News

NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.
NEWS Exciting new copper-gold discoveries at Tarraji-Yampi: Dive into the strong drilling results now
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.
Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation After just over a week, the thrill China’s latest stimulus announcements put into world markets has started to subside.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

Featured News

NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
NEWS High-grade gold discovery at Didievi Project: First drill results reveal impressive 33m intercept at 2.4g/t
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.